Related references
Note: Only part of the references are listed.Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine
Denise Hilfiker-Kleiner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Incidence, mortality, and racial differences in peripartum cardiomyopathy
Somjot S. Brar et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
The Angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-κB activation
Sebastien P. Tabruyn et al.
MOLECULAR ENDOCRINOLOGY (2007)
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy
Denise Hilfiker-Kleiner et al.
CELL (2007)
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program
Lars G. Olsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin
Yazmin Macotela et al.
JOURNAL OF CELL SCIENCE (2006)
Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis
TE Battle et al.
CANCER RESEARCH (2006)
Peripartum cardiomyopathy:: inflammatory markers as predictors of outcome in 100 prospectively studied patients
K Sliwa et al.
EUROPEAN HEART JOURNAL (2006)
Usefulness of anti-oxidized LDL antibody determination for assessment of clinical control in patients with heart failure
J George et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
Pregnancy-associated cardiomyopathy - Clinical characteristics and a comparison between early and late presentation
U Elkayam et al.
CIRCULATION (2005)
Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Gαq transgenic mice
Y Hayakawa et al.
CIRCULATION (2003)
The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-κB
SP Tabruyn et al.
MOLECULAR ENDOCRINOLOGY (2003)
B-type natriuretic peptide in cardiovascular disease
JA de Lemos et al.
LANCET (2003)
B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction
AM Richards et al.
CIRCULATION (2003)
Oxidized LOw-density lipoprotein sensitizes human vascular smooth muscle cells to FAS (CD95)-mediated apoptosis
S Takarada et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2003)
Induction of interferon regulatory factor 1 expression in human dermal endothelial cells by interferon-gamma and tumor necrosis factor-alpha is transcriptionally regulated and requires iron
AK Gira et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy
K Sliwa et al.
EUROPEAN JOURNAL OF HEART FAILURE (2002)
Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis
AM Corbacho et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Peripartum cardiomyopathy - National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review
GD Pearson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
